Course Provider
Learning Objectives
Describe that IgA is a progressive, autoimmune, chronic kidney disease, and the most common primary glomerulonephritis.
Discuss common presentation of IgA nephropathy and what is required to assess for IgA nephropathy.
Explain the Impact on daily living and impairment in work-related activities due to IgA nephropathy for patients in the U.S.
Discuss the outcome of the four-hit process and clinical manifestations related to Kidney injury.
Discuss the need for targeted treatment that specifically addressed the underlying case of IgA nephropathy and ultimately delays progression to kidney failure